Doximity Acquires Pathway, a Leader in AI Clinical Reference

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announces that it has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. Physicians make up half of Pathway’s team. Over the past seven years, they’ve assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway’s model outperforms others in clinical accuracy, recently scoring a record 96% on the U.S. Medical Licensing Examination (USMLE) benchmark.

Read the full article: Doximity Acquires Pathway, a Leader in AI Clinical Reference //

Source: https://www.businesswire.com/news/home/20250807262957/en/Doximity-Acquires-Pathway-a-Leader-in-AI-Clinical-Reference

Scroll to Top